Akebia Therapeutics Inc. buy HC Wainwright
Start price
28.08.23
/
50%
€1.27
Target price
28.08.24
€3.47
Performance (%)
-10.79%
Price
14.05.24
€1.13
Summary
This prediction is currently active. The price of Akebia Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.79%. This prediction currently runs until 28.08.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akebia Therapeutics Inc. | -14.183% | -14.183% |
iShares Core DAX® | 2.749% | 4.620% |
iShares Nasdaq 100 | 0.470% | -0.331% |
iShares Nikkei 225® | -2.930% | -5.556% |
iShares S&P 500 | 0.679% | 0.631% |
Comments by HC_Wainwright for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating. They now have a $3.75 price target on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by HC_Wainwright for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.82
28.03.24
28.03.24
€5.55
28.03.25
28.03.25
-37.88%
14.05.24
14.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
17.11.23
17.11.23
€4.60
17.11.24
17.11.24
26.94%
14.05.24
14.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.11
27.09.23
27.09.23
€3.55
27.09.24
27.09.24
1.89%
14.05.24
14.05.24